Finasteride Lowers Risk for Prostate Cancer, But Offers No Mortality Advantage (FREE)

By Joe Elia Finasteride reduces the risk for developing prostate cancer, but it may be linked to more high-grade cancers and offers no mortality benefit, according to an updated New England Journal of Medicine study.Researchers did …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news